Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus

Autoimmunity Reviews

Volumn 8, Issue 8, 2009, Pages 687-691

  Tsirogianni, Alexandra ^a   Pipi, Elena ^a   Soufleros, Konstantinos ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

ICA; Organ specific autoantibodies; T1DM

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INSULIN ANTIBODY; INSULINOMA ANTIGEN 2; UNCLASSIFIED DRUG;

ADDISON DISEASE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGENIC MODULATION; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CELIAC DISEASE; CELL LOSS; CELLULAR IMMUNITY; CROSS REACTION; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GASTRITIS; GENETIC PREDISPOSITION; HUMAN; HYPOINSULINEMIA; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PREVALENCE; RADIOIMMUNOASSAY; REVIEW;

AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; ISLETS OF LANGERHANS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8;

EID: 67349199793     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.019     Document Type: Review

References (40)

1. Knip M., and Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7 (2008) 550-557
2. Bottazzo G.F., Florin-Christensen A., and Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2 (1974) 1279-1283
3. Lernmark A., Freedman Z.R., Hofmann C., Rubenstein A.H., Steiner D.F., Jackson R.L., et al. Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med 299 (1978) 375-380
4. Decochez K., Tits J., Coolens J.L., Van Gaal L., Krzentowski G., Winnock F., et al. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care 23 (2000) 838-844
5. Atkinson M.A., and Maclaren N.K. Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 92 (1993) 1608-1616
6. Knip M., Karjalainen J., and Akerblom H.K. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group. Diabetes Care 21 (1998) 1670-1673
7. Bingley P.J., Bonifacio E., Shattock M., Gillmor H.A., Sawtell P.A., Dunger D.B., et al. Can islet cell antibodies predict IDDM in the general population?. Diabetes Care 16 (1993) 45-50
8. Kimpimaki T., Kulmala P., Savola K., Kupila A., Korhonen S., Simell T., et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87 (2002) 4572-4579
9. Jarvela I.Y., Juutinen J., Koskela P., Hartikainen A.L., Kulmala P., Knip M., et al. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 29 (2006) 607-612
10. Irvine W.J., Sawers J.S., Feek C.M., Prescott R.J., and Duncan L.J. The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in Diabetes mellitus. J Clin Lab Immunol 2 (1979) 23-26
11. Greenbaum C.J., Palmer J.P., Nagataki S., Yamaguchi Y., Molenaar J.L., Van Beers W.A., et al. Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop. Diabetes 41 (1992) 1570-1574
12. Srikanta S., and Eisenbarth G.S. Islet cell antigens. Initial studies of their biology and function. Mol Biol Med 3 (1986) 113-127
13. Mansson L., Torn C., and Landin-Olsson M. Islet cell antibodies represent autoimmune response against several antigens. Int J Exp Diabetes Res 2 (2001) 85-90
14. Atkinson M.A., Maclaren N.K., Riley W.J., Winter W.E., Fisk D.D., and Spillar R.P. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus?. Diabetes 35 (1986) 894-898
15. Greenbaum C.J., Palmer J.P., Kuglin B., and Kolb H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab 74 (1992) 1040-1044
16. Devendra D., Galloway T.S., Horton S.J., Evenden A., Keller U., and Wilkin T.J. The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes. Diabetologia 46 (2003) 802-809
17. Williams A.J., Norcross A.J., Dix R.J., Gillespie K.M., Gale E.A., and Bingley P.J. The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence. Diabetologia 46 (2003) 1354-1356
18. Ziegler A.G., Hummel M., Schenker M., and Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48 (1999) 460-468
19. Bingley P.J., Bonifacio E., and Mueller P.W. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 52 (2003) 1128-1136
20. Tsirogianni A., Soufleros K., Pipi E., Voulgari E., and Papasteriades C. Specificity of islet cell autoantibodies and co-existence with other organ specific autoantibodies in type 1 diabetes mellitus (Abstract). 6th International Congress on Autoimmunity Porto, Portugal (2008)
21. Bonifacio E., Atkinson M., Eisenbarth G., Serreze D., Kay T.W., Lee-Chan E., et al. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 50 (2001) 2451-2458
22. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., et al. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347 (1990) 151-156
23. Bu D.F., Erlander M.G., Hitz B.C., Tillakaratne N.J., Kaufman D.L., Wagner-McPherson C.B., et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A 89 (1992) 2115-2119
24. Hagopian W.A., Michelsen B., Karlsen A.E., Larsen F., Moody A., Grubin C.E., et al. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase. Diabetes 42 (1993) 631-636
25. Oak S., Gilliam L.K., Landin-Olsson M., Torn C., Kockum I., Pennington C.R., et al. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci U S A 105 (2008) 5471-5476
26. Petersen J.S., Russel S., Marshall M.O., Kofod H., Buschard K., Cambon N., et al. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42 (1993) 484-495
27. Kim J., Richter W., Aanstoot H.J., Shi Y., Fu Q., Rajotte R., et al. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes 42 (1993) 1799-1808
28. Rahmati K., Lernmark A., Becker C., Foltyn-Zadura A., Larsson K., Ivarsson S.A., et al. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits. Clin Lab 54 (2008) 227-235
29. Turner R., Stratton I., Horton V., Manley S., Zimmet P., Mackay I.R., et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350 (1997) 1288-1293
30. Aguilar-Diosdado M., Parkinson D., Corbett J.A., Kwon G., Marshall C.A., Gingerich R.L., et al. Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes 43 (1994) 418-425
31. Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oles J., Hicks J.M., et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152 (1994) 3183-3188
32. Lan M.S., Wasserfall C., Maclaren N.K., and Notkins A.L. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 93 (1996) 6367-6370
33. Payton M.A., Hawkes C.J., and Christie M.R. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96 (1995) 1506-1511
34. Solimena M., Dirkx Jr. R., Hermel J.M., Pleasic-Williams S., Shapiro J.A., Caron L., et al. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 15 (1996) 2102-2114
35. Lampasona V., Bearzatto M., Genovese S., Bosi E., Ferrari M., and Bonifacio E. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 157 (1996) 2707-2711
36. Palomer X., Mauricio D., Rodriguez-Espinosa J., Zapico E., Mayoral C., Gonzalez-Sastre F., et al. Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum. Clin Chem 50 (2004) 1378-1382
37. Irivine W.J., Clarke B.F., Scarth L., and Duncan L.J. The incidence of thyroid and gastric autoimmunity in patients with diabetes mellitus. Clin Sci 37 (1969) 570
38. Frohlich-Reiterer E.E., Hofer S., Kaspers S., Herbst A., Kordonouri O., Schwarz H.P., et al. Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus-data from a German/Austrian multicentre survey. Pediatr Diabetes 9 (2008) 546-553
39. Yu L., Brewer K.W., Gates S., Wu A., Wang T., Babu S.R., et al. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 84 (1999) 328-335
40. De Block C.E., De Leeuw I.H., and Van Gaal L.F. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab 93 (2008) 363-371